Paulina Koszalka
Clayton, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses.
Journal: Viruses
Published: October 27, 2023
Effect of Baloxavir and Oseltamivir in Combination on Infection with Influenza Viruses with PA/I38T or PA/E23K Substitutions in the Ferret Model.
Journal: mBio
Published: August 08, 2022
Preclinical and clinical developments for combination treatment of influenza.
Journal: PLoS pathogens
Published: May 13, 2022
Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model.
Journal: Communications biology
Published: May 05, 2022
Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model.
Journal: PLoS pathogens
Published: October 16, 2020
Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir.
Journal: Antiviral research
Published: January 01, 2020
Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission.
Journal: PLoS pathogens
Published: December 03, 2019
A rapid pyrosequencing assay for the molecular detection of influenza viruses with reduced baloxavir susceptibility due to PA/I38X amino acid substitutions.
Journal: Influenza and other respiratory viruses
Published: November 20, 2019
Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012-2018.
Journal: Antiviral research
Published: November 30, 2018
Influenza antivirals currently in late-phase clinical trial.
Journal: Influenza and other respiratory viruses
Published: January 26, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026